![]() |
Custom Search
|
A large-scale clinical trial of a candidate HIV vaccine - which previously showed promise in smaller studies in the United States and elsewhere - has now opened in South Africa. The study plans to enroll up to 3,000 HIV-negative men and women, ... Read the entire article at National Institutes of Health | ||||
|